Recommendations for optimal care of the fragility fracture patient to reduce the risk of future fracture

被引:54
作者
Bouxsein, ML
Kaufman, J
Tosi, L
Cummings, S
Lane, J
Johnell, O
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Santa Clarita Orthoped & Sports Med Grp, Santa Clarita, CA USA
[4] Childrens Natl Med Ctr, Div Orthopaed Surg, Bone Hlth Program, Washington, DC 20010 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Calif Pacific Med Ctr, Inst Res, San Francisco Coordinating Ctr, San Francisco, CA USA
[7] Hosp Special Surg, Metab Bone Dis Serv, New York, NY 10021 USA
[8] UMAS, Dept Orthopaed Surg, Malmo, Sweden
关键词
D O I
10.5435/00124635-200411000-00003
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Fragility fractures resulting from low trauma events such as a fall from standing height affect up to one half of women and one third of men after age 50 years. These fractures are frequently associated with osteoporosis. History of a fragility fracture is among the strongest risk factors for future fracture. Therefore, optimal care of the patient with a fragility fracture includes not only treatment of the presenting fracture itself but also evaluation and treatment of the underlying cause or causes to prevent future fractures. However, despite the availability of therapeutic agents that reduce fracture risk among osteoporotic patients who have had a fracture, most patients with fragility fractures are not evaluated for osteoporosis or treated adequately to reduce the risk of future fracture. Orthopaedic surgeons are the first and often the only physicians seen by fracture patients. Thus, they have the unique opportunity to serve as primary advocates to ensure that appropriate action is taken to reduce the risk of future fracture.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 48 条
[1]  
Adachi JD, 2001, ARTHRITIS RHEUM-US, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO
[2]  
2-W
[3]   How well are community-living women treated for osteoporosis after hip fracture? [J].
Bellantonio, S ;
Fortinsky, R ;
Prestwood, K .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (09) :1197-1204
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]   Health professional's guide to rehabilitation of the patient with osteoporosis [J].
Bonner, FJ ;
Sinaki, M ;
Grabois, M ;
Shipp, KM ;
Lane, JM ;
Lindsay, R ;
Gold, DT ;
Cosman, F ;
Bouxsein, ML ;
Weinstein, JN ;
Gallagher, RM ;
Melton, LJ ;
Salcido, R ;
Gordon, SL .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (Suppl 2) :S1-S22
[6]   Mortality after all major types of osteoporotic fracture in men and women: an observational study [J].
Center, JR ;
Nguyen, TV ;
Schneider, D ;
Sambrook, PN ;
Eisman, JA .
LANCET, 1999, 353 (9156) :878-882
[7]   EFFECT OF CALCIUM AND CHOLECALCIFEROL TREATMENT FOR 3 YEARS ON HIP-FRACTURES IN ELDERLY WOMEN [J].
CHAPUY, MC ;
ARLOT, ME ;
DELMAS, PD ;
MEUNIER, PJ .
BRITISH MEDICAL JOURNAL, 1994, 308 (6936) :1081-1082
[8]   A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study [J].
Chesnut, CH ;
Silverman, S ;
Andriano, K ;
Genant, H ;
Gimona, A ;
Harris, S ;
Kiel, D ;
LeBoff, M ;
Maricic, M ;
Miller, P ;
Moniz, C ;
Peacock, M ;
Richardson, P ;
Watts, N ;
Baylink, D .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :267-276
[9]   Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis [J].
Chesnut, CH ;
Skag, A ;
Christiansen, C ;
Recker, R ;
Stakkestad, JA ;
Hoiseth, A ;
Felsenberg, D ;
Huss, H ;
Gilbride, J ;
Schimmer, RC ;
Delmas, PD .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1241-1249
[10]   An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture [J].
Chevalley, T ;
Hoffmeyer, P ;
Bonjour, JP ;
Rizzoli, R .
OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) :450-455